Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Furberg: Clinical implications of recent findings from the Antihypertensive and Lipid-Lowering.... (0.12 sec) 

Clinical implications of recent findings from the Antihypertensive and Lipid-Lowering …

- annals.org [PDF] 
CD Furberg, BM Psaty, M Pahor, MH … - Annals of Internal Medicine, 2001 - Am Coll Physicians
Several recent comparative trials in hypertension have reported that similar
blood pressure reductions may not necessarily trans- late into similar
reductions in risk for cardiovascular complications. Thus, the method used ...
Cited by 48 - Related articles - BL Direct - All 3 versions

Prescribing patterns for antihypertensive drugs after the Antihypertensive and Lipid- …


F Xie, DB Petitti, W Chen - American journal of hypertension, 2005 - Elsevier
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
(ALLHAT) reported that primary cardiovascular outcomes were the same in
hypertensive patients treated with thiazide-type diuretics as in those ...
Cited by 22 - Related articles - All 4 versions

Trends in antihypertensive drug therapy of ambulatory patients by US office-based …

- ahajournals.org
CR Nelson, DA Knapp - Hypertension, 2000 - Am Heart Assoc
Abstract—This study assessed trends from 1980 to 1995 in ambulatory patients'
antihypertensive drug therapy by US office-based physicians for visits in which
hypertension was the principal diagnosis and compared these trends with the ...
Cited by 60 - Related articles - BL Direct - All 6 versions

Blood-pressure-lowering treatment


M Pahor, BM Psaty, MH Alderman, WB … - The Lancet, 2001 - Elsevier
Our main objective was to find out whether calcium antagonists used as
first-line therapy are better than, equal to, or worse than other treatments in
lowering the incidence of cardiovascular complications of hypertension. The ...
Cited by 7 - Related articles - BL Direct - All 2 versions

Bruce Psaty and the risks of calcium channel blockers


RA Deyo - Quality and Safety in Health Care, 2002 - qshc.bmj.com
On a fine March day in 1995 Dr Bruce Psaty ascended the podium to present a
scientific paper as he had many times before. At a hotel in San Antonio he was
speaking before the Epidemiology and Prevention Council of the American ...
Related articles - BL Direct - All 7 versions

The evidence base for tight blood pressure control in the management of type 2 diabetes …


V Snow, KB Weiss, C Mottur-Pilson - Annals of internal medicine, 2003 - Am Coll Physicians
Diabetes mellitus is a leading cause of morbidity and death in the United
States. Type 2 diabetes mellitus accounts for the majority of affected persons
(90% to 95%) and affects older adults, particularly those older than 50 ...
Cited by 51 - Related articles - BL Direct - All 6 versions

INSIGHT and NORDIL


A Fournier, A Georgita, B Bouffandeau, R … - The Lancet, 2000 - Elsevier
The difficulty with such a meta-analysis will be, however, to take into account
the fact that in the most recent comparative studies, calcium antagonists and
ACE inhibitors have been compared with conventional therapy such as ...
Cited by 1 - Related articles - All 2 versions

Differences Between Primary vs Secondary Prevention Trials Regarding the Stroke Protective …


A Fournier, R Oprisiu, JM Achard, OH … - Archives of Internal Medicine, 2001 - archinte.highwire.org
In the very interesting case-control study by Klungel et al, 1 we noted 2
intriguing observations about which we would like to comment: (1) among patients
without cardiovascular complication treated with monotherapy, the risk ...
Related articles - BL Direct - All 2 versions

Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type …

- annals.org [PDF] 
T Berl, LG Hunsicker, JB Lewis, MA Pfeffer, … - Annals of internal medicine, 2003 - Am Coll Physicians
Background: Patients with diabetes have increased risk for ad- verse
cardiovascular events. Angiotensin-converting enzyme inhib- itors are protective
in type 1 diabetes. However, no definitive studies have examined the use of ...
Cited by 168 - Related articles - BL Direct - All 7 versions

Management of hypertension in patients with type 2 diabetes mellitus: guidelines based on …

- annals.org [PDF] 
NM Kaplan - Annals of internal medicine, 2001 - Am Coll Physicians
Hypertension and diabetes are becoming increasingly common. Most patients with
both disorders have a markedly worsened risk for premature microvascular and
macrovascular complications. The appropriate management of the hypertension ...
Cited by 70 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google